| | | | |
CUSIP No. 77634L 105 | | Schedule 13D | | Page 11 of 13 |
This Amendment No. 10 (the “Amendment”) amends and supplements the Schedule 13D filed by the Reporting Persons on July 1, 2022, as amended on October 3, 2023, February 7, 2024, February 26, 2024, April 29, 2024, May 7, 2024, June 14, 2024, July 1, 2024, July 2, 2024 and August 5, 2024 (collectively, the “Original Schedule 13D” and, as amended and supplemented by this Amendment, this “Statement”), with respect to the Common Stock. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Original Schedule 13D.
Item 4. Purpose of Transaction.
Item 4 of the Original Schedule 13D is amended and supplemented by adding the following:
On November 19, 2024, the Issuer completed its merger with Merger Sub and all shares of Common Stock beneficially owned by the Reporting Persons were cancelled and converted into the right to receive $14.30 per share in cash.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Original Schedule 13D is amended and restated in its entirety as follows:
The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Statement and the information set forth or incorporated in Items 2, 3, 4 and 6 is incorporated by reference in its entirety into this Item 5.
(a) and (b) The Reporting Persons do not beneficially own any shares of Common Stock.
(c) Other than as disclosed herein, none of the Reporting Persons has effected any transaction in the shares of Common Stock during the past 60 days.
(d) The Reporting Persons do not beneficially own any shares of Common Stock.
(e) November 19, 2024.